Front Line Medical Gets 510(k) Clearance for Bleeding Control System
Front Line Medical Technologies has received the FDA’s 510(k) clearance for its COBRA-OS arterial occlusion device.
The system deploys an endovascular balloon in the aorta to temporarily stem blood flow below the device and increase blood flow above it to the brain and heart. It can also provide full occlusion, intermittent occlusion or partial occlusion, depending on the patient’s needs.
COBRA-OS is currently the smallest device on the market for use in endovascular balloon occlusion procedures, the London, Ontario-based company said.